Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.antiviral.2015.12.011

http://scihub22266oqcxt.onion/10.1016/j.antiviral.2015.12.011
suck pdf from google scholar
26738783!ä!26738783

suck abstract from ncbi


Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid26738783      Antiviral+Res 2016 ; 126 (ä): 69-80
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Immuno-modulating properties of saliphenylhalamide, SNS-032, obatoclax, and gemcitabine #MMPMID26738783
  • Soderholm S; Anastasina M; Islam MM; Tynell J; Poranen MM; Bamford DH; Stenman J; Julkunen I; Sauliene I; De Brabander JK; Matikainen S; Nyman TA; Saelens X; Kainov D
  • Antiviral Res 2016[Feb]; 126 (ä): 69-80 PMID26738783show ga
  • Influenza A viruses (IAVs) impact the public health and global economy by causing yearly epidemics and occasional pandemics. Several anti-IAV drugs are available and many are in development. However, the question remains which of these antiviral agents may allow activation of immune responses and protect patients against co- and re-infections. To answer to this question, we analysed immuno-modulating properties of the antivirals saliphenylhalamide (SaliPhe), SNS-032, obatoclax, and gemcitabine, and found that only gemcitabine did not impair immune responses in infected cells. It also allowed activation of innate immune responses in lipopolysaccharide (LPS)- and interferon alpha (IFNalpha)-stimulated macrophages. Moreover, immuno-mediators produced by gemcitabine-treated IAV-infected macrophages were able to prime immune responses in non-infected cells. Thus, we identified an antiviral agent which might be beneficial for treatment of patients with severe viral infections.
  • |Amides/pharmacology[MESH]
  • |Antineoplastic Agents/*pharmacology[MESH]
  • |Antiviral Agents/*pharmacology[MESH]
  • |Cells, Cultured[MESH]
  • |Coinfection/drug therapy/virology[MESH]
  • |Cytokines/metabolism[MESH]
  • |Deoxycytidine/analogs & derivatives/pharmacology[MESH]
  • |Gemcitabine[MESH]
  • |Humans[MESH]
  • |Immunity, Innate/drug effects[MESH]
  • |Immunologic Factors/*pharmacology[MESH]
  • |Indoles[MESH]
  • |Influenza A virus/drug effects/physiology[MESH]
  • |Influenza, Human/*drug therapy/immunology/virology[MESH]
  • |Interferon-alpha/drug effects/immunology[MESH]
  • |Lipopolysaccharides/pharmacology[MESH]
  • |Macrophages/*drug effects/immunology/*virology[MESH]
  • |Oxazoles/pharmacology[MESH]
  • |Phosphoproteins/metabolism[MESH]
  • |Pyrroles/pharmacology[MESH]
  • |RNA, Viral/biosynthesis[MESH]
  • |Salicylates/pharmacology[MESH]
  • |Thiazoles/pharmacology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box